Pharmaceutical Formulation Using Polymer Nanocomposites

A polymer matrix and nanometer-sized reinforcements (nanofillers), such as nanoparticles, nanotubes, or nanoclays, combine to form nanocomposites. To improve or give the composite material new qualities, these nanofillers—which are usually between 1 and 100 nanometers in size—are added to the polymer matrix. Comparing nanofillers to the unaltered polymer, the former enhances qualities including mechanical strength, thermal stability, chemical resistance, and barrier qualities. In the pharmaceutical industry, nanocomposites can be utilized to create sophisticated drug delivery systems. The nanofillers give targeted distribution to particular body regions, improve stability, increase drug solubility, and allow controlled drug release. Nanocomposites are very useful in a variety of medical and therapeutic applications because of the nanofillers’ enormous surface area and tiny size, which enable improved interaction with biological systems. Hydrogels, films, microspheres, liposomes, nanotubes, emulsions, gel systems, micelles, coatings, injections, and many other are among the types that are involved. The mechanical strength and bioadhesiveness of the delivery systems can be enhanced by the synergistic effects of adding nanomaterials such as metal oxide nanomaterials, silica nanoparticles, or carbon nanotubes to polymer matrices.